PAPER Dodel R
SEARCH RESULTS
330988 RESULTS
PAPER Thomas AA, Hunt KW, Volgraf M, Watts RJ, Liu X, Vigers G, Smith D, Sammond D, Tang TP, Rhodes SP, Metcalf AT, Brown KD, Otten JN, Burkard M, Cox AA, Do MK, Dutcher D, Rana S, DeLisle RK, Regal K, Wright AD, Groneberg R, Scearce-Levie K, Siu M, Purkey HE, Lyssikatos JP, Gunawardana IW
Discovery of 7-tetrahydropyran-2-yl chromans: β-site amyloid precursor protein cleaving enzyme 1 (BACE1) inhibitors that reduce amyloid β-protein (Aβ) in the central nervous system.
J Med Chem. 2014 Feb 13;57(3):878-902. Epub 2014 Jan 22 PubMed: 24397738PAPER Schweigert O, Dewitz C, Möller-Hackbarth K, Trad A, Garbers C, Rose-John S, Scheller J
Soluble T cell immunoglobulin and mucin domain (TIM)-1 and-4 generated by A Disintegrin And Metalloprotease (ADAM)-10 and-17 bind to phosphatidylserine.
Biochim Biophys Acta. 2014 Feb;1843(2):275-87. Epub 2013 Nov 25 PubMed: 24286866PAPER Folgosa L, Zellner HB, El Shikh ME, Conrad DH
Disturbed follicular architecture in B cell A disintegrin and metalloproteinase (ADAM)10 knockouts is mediated by compensatory increases in ADAM17 and TNF-α shedding.
J Immunol. 2013 Dec 15;191(12):5951-8. Epub 2013 Nov 13 PubMed: 24227779PAPER Yacoub D, Benslimane N, Al-Zoobi L, Hassan G, Nadiri A, Mourad W
CD154 is released from T-cells by a disintegrin and metalloproteinase domain-containing protein 10 (ADAM10) and ADAM17 in a CD40 protein-dependent manner.
J Biol Chem. 2013 Dec 13;288(50):36083-93. Epub 2013 Nov 4 PubMed: 24189063PAPER Halliday GM, Leverenz JB, Schneider JS, Adler CH
The neurobiological basis of cognitive impairment in Parkinson's disease.
Mov Disord. 2014 Apr 15;29(5):634-50. PubMed: 24757112PAPER Hogg MC, Prehn JH
Endonuclease-G and the pathways to dopaminergic neurodegeneration: a question of location?
EMBO J. 2013 Nov 27;32(23):3014-6. Epub 2013 Oct 25 PubMed: 24162725PAPER El Mendili MM, Cohen-Adad J, Pelegrini-Issac M, Rossignol S, Morizot-Koutlidis R, Marchand-Pauvert V, Iglesias C, Sangari S, Katz R, Lehericy S, Benali H, Pradat PF
Multi-parametric spinal cord MRI as potential progression marker in amyotrophic lateral sclerosis.
PLoS One. 2014;9(4):e95516. Epub 2014 Apr 22 PubMed: 24755826PAPER Branco LM Jr, De Albuquerque M, De Andrade HM, Bergo FP, Nucci A, França MC
Spinal cord atrophy correlates with disease duration and severity in amyotrophic lateral sclerosis.
Amyotroph Lateral Scler Frontotemporal Degener. 2014 Mar;15(1-2):93-7. Epub 2013 Nov 13 PubMed: 24219347PAPER Real RG, Herbert C, Kotchoubey B, Wessig C, Volkmann J, Kübler A
Psychophysiological correlates of coping and quality of life in patients with ALS.
Clin Neurophysiol. 2014 May;125(5):955-61. Epub 2013 Nov 6 PubMed: 24210996PAPER Jaiswal MK
Calcium, mitochondria, and the pathogenesis of ALS: the good, the bad, and the ugly.
Front Cell Neurosci. 2013;7:199. Epub 2013 Oct 31 PubMed: 24198760PAPER Pansarasa O, Rossi D, Berardinelli A, Cereda C
Amyotrophic lateral sclerosis and skeletal muscle: an update.
Mol Neurobiol. 2014 Apr;49(2):984-90. Epub 2013 Nov 8 PubMed: 24198230PAPER Traxinger K, Kelly C, Johnson BA, Lyles RH, Glass JD
Prognosis and epidemiology of amyotrophic lateral sclerosis: Analysis of a clinic population, 1997-2011.
Neurol Clin Pract. 2013 Aug;3(4):313-320. PubMed: 24195020PAPER Christidi F, Zalonis I, Kyriazi S, Rentzos M, Karavasilis E, Wilde EA, Evdokimidis I
Uncinate fasciculus microstructure and verbal episodic memory in amyotrophic lateral sclerosis: a diffusion tensor imaging and neuropsychological study.
Brain Imaging Behav. 2013 Nov 6; PubMed: 24190400PAPER Todd PK
Making sense of the antisense transcripts in C9FTD/ALS.
Acta Neuropathol. 2013 Dec;126(6):785-7. PubMed: 24178412Current Filters
No filters selected